“Democrats love to avoid it, and Republicans love to lie about it. But later-abortion care has never been more important.” Amy Littlefield, abortion access correspondent for the Nation and author of the new book Killers of Roe: My Investigation into the Mysterious Death of Abortion Rights, talks to us about her new article for the Nation, What Would It Mean to Defend All Abortions? Garin Marschall, co-founder of Patient Forward, joins to discuss the importance of protecting access to later abortion care.

In April 2025, some organizations and health centers receiving Title X funding were given sudden notice by the current administration that critical funding would be withheld. This action by the federal government threatens roughly $65.8 million in Title X funds and implicates an estimated 846,000 patients. It has resulted in massive layoffs, stopped contracts, mental strain, and confusion for both employees and patients. We sit down with CEOs and executive directors of some of these impacted organizations, including:

Stephanie McDowell, Executive Director of Bridgercare in Montana

Ayana Bradshaw, President and CEO of AccessMatters in Pennsylvania

Amy Moy, Co-CEO with Essential Access Health in California and Hawaii

Medina v. Planned Parenthood South Atlantic was a Supreme Court case this term that specifically targeted efforts to kick Planned Parenthood and other reproductive healthcare providers out of Medicaid. In a 6-3 ruling, the Supreme Court sided against access to care. Dr. Regina Davis Moss, President and CEO of In Our Own Voice, National Black Women’s Reproductive Justice Agenda, sits down to talk with us about Medina v. Planned Parenthood and how this case is a direct assault on hard-fought reproductive justice progress.

From Skrmetti to Medina to Mahmoud, the Supreme Court has been busy issuing devastating rulings on cases that carry profound implications for LGBTQI+ health and rights and reproductive health and rights. Chris Geidner, author of Law Dork, sits down to talk with us about these recent cases out of the Supreme Court, and what these rulings mean for our rights and wellbeing.

In April 2025, some organizations and health centers receiving Title X funding were given sudden notice by the current administration that critical funding would be withheld. This action by the federal government threatens roughly $65.8 million in Title X funds and implicates an estimated 846,000 patients. It has resulted in massive layoffs, stopped contracts, mental strain, and confusion for both employees and patients. We sit down with co-founders and executive directors of some of these impacted organizations, including:

Michelle Trupiano, Executive Director for the Missouri Family Health Council, and

Danielle Lampton, and Jamie Bardwell, Co-Founder and Co-Executive Directors at Converge in Jackson, Mississippi

Immediately after the Dobbs v. Jackson Women’s Health Organization Supreme Court case that overturned Roe v. Wade,shock, sadness, and anger were predominant. But even still, abortion providers, abortion fund workers, and other advocates and leaders in the field provided, facilitated, and fought for access to care. Carole Joffe, professor of obstetrics, gynecology and reproductive sciences at the University of California, San Francisco and professor emerita of sociology at UC Davis, and David Cohen, law professor at Drexel's Klein School of Law in Philadelphia and pro bono counsel to a number of Pennsylvania abortion clinics, sit down to talk with us about their book, After Dobbs: How the Supreme Court Ended Roe but not Abortion.

2/3 of Massachusetts voters support expanding access to abortion later in pregnancy, according to recent polling. Massachusetts still has on the books a 24-week abortion ban, with additional exceptions later added. Jeanette Kincaid, Associate Director of Care Coordination at DuPont Clinic and Kate Dineen, abortion later in pregnancy patient and advocate and Board Member of Reproductive Equity Now, sit down to talk with us about Massachusetts’ abortion access status and the reality of exceptions.

The One Big Beautiful Bill is a reconciliation bill which passed the House and has moved on to the Senate. Included in this bill are provisions that would defund Planned Parenthood, threaten health insurance access, undermine access to abortion and gender-affirming-care nationwide, and raise costs on working families. Ianthe Metzger, Senior Director, Advocacy Communications at Planned Parenthood, sits down to talk with us about this insidious bill and how it, among other things, threatens the care Planned Parenthood provides.

Mifepristone is the first (and extremely safe) of two medications that people will take during a medication abortion—and access to it is under blatant attack in the courts. Dr. Ushma Upadhyay, Public Health Scientist based at University of California San Francisco, and Julia Kaye, Senior Staff Attorney with the ACLU’s Reproductive Freedom Project, sit down to talk with us about recent anti-abortion propaganda and how it could be used to shape the FDA’s regulations of medication abortion.